Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Experimental and molecular pathology (Print)

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yexmp.2010.01.001PMID 20079732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy.

  2009cited by this paper
• Increased expression of Annexin A2 in oral squamous cell carcinoma.

  2009cited by this paper
• Annexin II represents metastatic potential in clear-cell renal cell carcinoma

  2009cited by this paper
• Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas.

  2009cited by this paper
• Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer

  2008cited by this paper
• Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

  2007cited by this paper
• The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.

  2007cited by this paper
• Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.

  2007cited by this paper
• Angiostatin receptor annexin II in vascular tumors including angiosarcoma.

  2007cited by this paper
• The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis

  2006cited by this paper
• Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.

  2006cited by this paper
• Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.

  2006cited by this paper
• Tissue-type plasminogen activator is upregulated in metastatic breast cancer cells exposed to insulin-like growth factor-I.

  2005cited by this paper
• Metastasis-associated Protein S100A4 Induces Angiogenesis through Interaction with Annexin II and Accelerated Plasmin Formation*

  2005cited by this paper
• Tissue plasminogen activator expression in meningiomas and glioblastomas.

  2005cited by this paper
• Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro

  2004cited by this paper
• Angiostatin‐induced inhibition of endothelial cell proliferation/apoptosis is associated with the down‐regulation of cell cycle regulatory protein cdk5

  2004cited by this paper
• Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.

  2004cited by this paper
• Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry

  2004cited by this paper
• Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages.

  2004cited by this paper
• The urokinase plasminogen activator system as a target for prognostic studies in breast cancer

  2004cited by this paper
• Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo.

  2004cited by this paper
• Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome

  2004cited by this paper
• Angiostatin Inhibits Bone Metastasis Formation in Nude Mice through a Direct Anti-osteoclastic Activity*

  2003cited by this paper
• Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D

  2003cited by this paper
• Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

  2002cited by this paper
• Plasmin-induced Migration of Endothelial Cells

  2002cited by this paper
• Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells.

  2002cited by this paper
• Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.

  2002cited by this paper
• Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.

  2002cited by this paper
• Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

  2001cited by this paper
• The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin

  2001cited by this paper
• Plasmin and Matrix Metalloproteinases in Vascular Remodeling

  2001cited by this paper
• Extracellular Proteolysis and Angiogenesis

  2001cited by this paper
• An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

  2001cited by this paper
• Plasmin-Mediated Fibroblast Growth Factor-2 Mobilisation Supports Smooth Muscle Cell Proliferation in Human Saphenous Vein

  2001cited by this paper
• Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth.

  2000cited by this paper
• Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.

  1999cited by this paper
• Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.

  1999cited by this paper
• The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro

  1998cited by this paper
• Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest.

  1998cited by this paper
• Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice

  1998cited by this paper
• Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice.

  1997cited by this paper
• Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice

  1997cited by this paper
• Characterization of Cellular Binding Sites and Interactive Regions within Reactants Required for Enhancement of Plasminogen Activation by tPA on the Surface of Leukocytic Cells

  1996cited by this paper
• Angiostatin induces and sustains dormancy of human primary tumors in mice

  1996cited by this paper
• An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation.

  1994cited by this paper
• Annexin II marks astrocytic brain tumors of high histologic grade.

  1994cited by this paper
• An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II.

  1994cited by this paper
• Tissue-type plasminogen activator as marker of functional steroid receptors in human breast cancer.

  1993cited by this paper
• Biology and biochemistry of proteinases in tumor invasion.

  1993cited by this paper
• Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.

  1992cited by this paper
• Tissue-type plasminogen activator in plasma from breast cancer patients determined by enzyme-linked immunosorbent assay.

  1990cited by this paper
• Urokinase-type plasminogen activator antigen and early relapse in breast cancer.

  1989cited by this paper
• Basement membrane and the invasive activity of metastatic tumor cells.

  1986cited by this paper
• Ultrastructural study of the effects of tranexamic acid and urokinase on metastasis of Lewis lung carcinoma.

  1982cited by this paper
• Letter: Primary non-function in cadaver kidney transplants.

  1975cited by this paper
• Tumorigenesis and Neoplastic Progression Preferential Attachment of Peritoneal Tumor Metastases to Omental Immune Aggregates and Possible Role of a Unique Vascular Microenvironment in Metastatic Survival and Growth

  year unknowncited by this paper

• Annexin A2-dependent extracellular vesicle proteome modulates pre-metastatic stromal fibroblast behavior in triple-negative breast cancer

  2026cites this paper
• Novel exosomal circEGFR facilitates triple negative breast cancer autophagy via promoting TFEB nuclear trafficking and modulating miR-224-5p/ATG13/ULK1 feedback loop

  2024cites this paper
• The novel DNA methylation marker FIBIN suppresses non-small cell lung cancer metastasis by negatively regulating ANXA2.

  2024cites this paper
• Baicalin target protein, Annexin A2, is a target of new antitumor drugs

  2024cites this paper
• Promoter Hypomethylation Upregulates ANXA2 Expression in Pancreatic Cancer and is Associated with Poor Prognosis

  2023cites this paper
• Collagen-I influences the post-translational regulation, binding partners and role of Annexin A2 in breast cancer progression

  2023cites this paper
• CD44s-activated tPA/LRP1-NFκB pathway drives lamellipodia outgrowth in luminal-type breast cancer cells

  2023cites this paper
• The intricate role of annexin A2 in kidney: a comprehensive review

  2023cites this paper
• Macrophage Function Modulated by tPA Signaling in Mouse Experimental Kidney Disease Models

  2023cites this paper
• The role of Renin angiotensin aldosterone system in women with breast cancer before and after treatment

  2023cites this paper
• Molecular analysis of Annexin expression in cancer

  2022cites this paper
• KIFC1: A Reliable Prognostic Biomarker in Rb-positive Triple-negative Breast Cancer Patients Treated With Doxorubicin in Combination With Abemaciclib.

  2022cites this paper
• Protein profile of MCF-7 breast cancer cell line treated with lectin delivered by CaCO3NPs revealed changes in molecular chaperones, cytoskeleton, and membrane-associated proteins.

  2021cites this paper
• Annexin A2-Mediated Plasminogen Activation in Endothelial Cells Contributes to the Proangiogenic Effect of Adenosine A2A Receptors

  2021cites this paper
• Characterization and proteomic analysis of endometrial stromal cell-derived small extracellular vesicles.

  2021cites this paper
• The association between Annexin A2 and epithelial cell adhesion molecule in breast cancer cells

  2021influential citation
• Roles of the tissue-type plasminogen activator in immune response

  2021cites this paper
• Proteomic Research on the Antitumor Properties of Medicinal Mushrooms

  2021cites this paper
• NF-κB and tPA Signaling in Kidney and Other Diseases

  2020cites this paper
• Critical role and its underlying molecular events of the plasminogen receptor, S100A10 in malignant tumor and non-tumor diseases

  2020cites this paper
• Clinicopathological value and underlying molecular mechanism of annexin A2 in 992 cases of thyroid carcinoma

  2020cites this paper
• Annexin 2 protein expression is associated with breast cancer subtypes in African American women

  2020cites this paper
• Analysis of the uterine flush fluid proteome of healthy mares and mares with endometritis or fibrotic endometrial degeneration.

  2020cites this paper
• Prognostic features of Annexin A2 expression in prostate cancer.

  2020cites this paper
• Important role of annexin A2 (ANXA2) in new blood vessel development in vivo and human triple negative breast cancer (TNBC) growth.

  2020cites this paper
• Expression of Annexin A2 Promotes Cancer Progression in Estrogen Receptor Negative Breast Cancers

  2020cites this paper
• Annexin A2 in Inflammation and Host Defense

  2020cites this paper
• Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer

  2019cites this paper
• Dynamic Reorganization of Microtubule and Glioma Invasion.

  2019cites this paper
• Sp1 promotes cell migration and invasion in oral squamous cell carcinoma by upregulating Annexin A2 transcription.

  2019cites this paper
• Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism

  2019cites this paper
• ANXA2Tyr23 and FLNASer2152 phosphorylation associate with poor prognosis in hepatic carcinoma revealed by quantitative phosphoproteomics analysis.

  2019cites this paper
• Interaction of HE4 and ANXA2 exists in various malignant cells—HE4–ANXA2–MMP2 protein complex promotes cell migration

  2019cites this paper
• Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers

  2018cites this paper
• Production of bioactive recombinant human Eb‐peptide of pro‐IGF‐I and identification of binding components from the plasma membrane of human breast cancer cells (MDA‐MB‐231)

  2018cites this paper
• Chapter 13 Smooth Muscle and Extracellular Matrix Interactions in Health and Disease

  2018cites this paper
• Circulating tumor cells and coagulation-Minireview.

  2017cites this paper
• Annexin A2 functions downstream of c‑Jun N‑terminal kinase to promote skin fibroblast cell migration.

  2017cites this paper
• Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting

  2017cites this paper
• Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.

  2017cites this paper
• Complex Roles of Annexin A2 in Host Blood–Brain Barrier Invasion by Cryptococcus neoformans

  2017cites this paper
• Annexin A2 contributes to lung injury and fibrosis by augmenting factor Xa fibrogenic activity.

  2017cites this paper
• Role of Annexin A2 in the EGF-induced epithelial-mesenchymal transition in human CaSki cells.

  2017cites this paper
• The upregulation of annexin A2 after spinal cord injury in rats may have implication for astrocyte proliferation.

  2017cites this paper
• Developmental and pathological roles of BMP/follistatin-like 1 in the lung

  2017cites this paper
• Expression of circulating annexin A2 in hepatic diseases and hepatocellular carcinoma

  2017cites this paper
• Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer.

  2016cites this paper
• Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.

  2016cites this paper
• Annexin A2 Coordinates STAT3 to Regulate the Invasion and Migration of Colorectal Cancer Cells In Vitro

  2016cites this paper
• The Annexin a2 Promotes Development in Arthritis through Neovascularization by Amplification Hedgehog Pathway

  2016cites this paper
• Annexin 2A sustains glioblastoma cell dissemination and proliferation

  2016cites this paper
• [Molecular biological predictors for kidney cancer].

  2016cites this paper
• Investigating the role of Annexin A2 in Epidermal Growth Factor (EGF) induced signalling in cancer

  2015cites this paper
• Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma

  2015cites this paper
• The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them

  2015cites this paper
• Cell surface interaction of annexin A2 and galectin-3 modulates epidermal growth factor receptor signaling in Her-2 negative breast cancer cells

  2015cites this paper
• A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level.

  2015cites this paper
• MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression

  2015cites this paper
• Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells

  2015cites this paper
• RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway

  2015cites this paper
• Atorvastatin protects endothelial colony-forming cells against H2O2-induced oxidative damage by regulating the expression of annexin A2

  2015cites this paper
• Association of annexin A2 with cancer development (Review).

  2015cites this paper
• Smooth Muscle and Extracellular Matrix Interactions in Health and Disease

  2015cites this paper
• Annexin A2 silencing enhances apoptosis of human umbilical vein endothelial cells in vitro.

  2015cites this paper
• From Plasminogen to Plasmin: Role of Plasminogen Receptors in Human Cancer

  2014cites this paper
• P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells.

  2014cites this paper
• Reciprocal Modulation of Surface Expression of Annexin A2 in a Human Umbilical Vein Endothelial Cell-Derived Cell Line by Eicosapentaenoic Acid and Docosahexaenoic Acid

  2014cites this paper
• Pregnancy-induced changes in metabolome and proteome in ovine uterine flushings†

  2014cites this paper
• Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors

  2014cites this paper
• Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies

  2014cites this paper
• ERG Oncoprotein Inhibits ANXA2 Expression and Function in Prostate Cancer

  2014cites this paper
• High expression of S100A4 and endoglin is associated with metastatic disease in head and neck squamous cell carcinoma

  2014cites this paper
• Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell model.

  2014cites this paper
• Regulation of pulmonary inflammation by mesenchymal cells.

  2014cites this paper
• On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity.

  2014cites this paper
• Role of annexin A2 in ovarian cancer metastasis.

  2014influential citation
• Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer

  2014cites this paper
• MicroRNA-23b regulates cellular architecture and impairs motogenic and invasive phenotypes during cancer progression

  2013cites this paper
• Protein interactions between surface annexin A2 and S100A10 mediate adhesion of breast cancer cells to microvascular endothelial cells

  2013cites this paper
• Domains I and IV of Annexin A2 Affect the Formation and Integrity of In Vitro Capillary-Like Networks

  2013cites this paper
• Increased annexin A1 and A2 levels in bronchoalveolar lavage fluid are associated with resistance to respiratory disease in beef calves

  2013cites this paper
• PRODUCTION AND CHARACTERISTICS OF ANTIBODIES AGAINST K1-3 FRAGMENT OF HUMAN PLASMINOGEN

  2013cites this paper
• Prognostic and diagnostic significance of annexin A2 in colorectal cancer

  2013cites this paper
• Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis

  2013cites this paper
• Endocrine actions of IFNT during early ruminant pregnancy

  2013cites this paper
• Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis

  2013cites this paper
• Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease

  2013cites this paper
• Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells.

  2013cites this paper
• Studies into the interaction between the plasminogen activating system and the blood-brain barrier

  2013cites this paper
• Annexin A2 Versus Afp as An Efficient Diagnostic Serum Marker for Hepatocellular Carcinoma

  2013cites this paper
• Identification of annexin II as a novel secretory biomarker for breast cancer

  2013cites this paper
• Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment.

  2013cites this paper
• Prognostic significance of annexin II expression in non-small cell lung cancer

  2013cites this paper
• Annexins A1 and A2 as potential biomarkers of stress and respiratory disease susceptibility

  2013cites this paper
• Annexin A2 System in Human Biology: Cell Surface and Beyond

  2013cites this paper
• Microcalcifications in breast cancer: Lessons from physiological mineralization.

  2013cites this paper
• Role of Bone Disease in the Pathogenesis of Multiple Myeloma

  2013cites this paper
• The plasminogen activation system: new targets in lung inflammation and remodeling.

  2013cites this paper
• Annexin A2 Heterotetramer: Structure and Function

  2013cites this paper
• Annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically.

  2013cites this paper